A Comparison Study for Unstable Sacrum/Pelvis and Acetabular Fracture Treated With Open Reduction and Internal Fixation With Minimally Invasive Internal Fixation
Tranditional open reduction and internal fixation: Under navigation and bone desity projecting method assisted 3D simulation and printing for minimal invasive surgrey
Study summary
Unstable sacral/pelvic or acetabular fracture are severe high energy fractures Surgical intervention are necessary after patient's conditions are stable. The complexity of local anatomical structure, the nearby major vessels, organ and visceral structures make the operations difficult and in high risks.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. 18 years old and above with the appropriate informed consent
2. traumatic pelvic or acetabular fracture with 2018 AO/OTA classification
3. a minimum of 48 months postoperative follow-ups
Exclusion Criteria:
1. pelvic or acetabular fractures that were pathological or non-traumatic in nature
2. patients with incomplete follow-up details
3. patients who denied surgical management
4. patients who received external fixation as part of their treatment strategy
Primary outcome measure(s)
EQ-VAS — Post-operative at 48th month The EQ-VAS is a vertical visual analogue scale that takes values between 100 (best imaginable health) and 0 (worst imaginable health), on which patients provide a global assessment of their health.
EQ-5D — Post-operative at 48th month EQ-5D is an instrument which evaluates the generic quality of life developed in Europe and widely used.
Majeed pelvic score — Post-operative at 48th month he Majeed scoring system is a disease-specific outcome measure that was originally designed to assess pelvic injuries.
Trial sites (1)
Facility
City
Region
Status
China Medical University Hospital
Taichung
North District
Recruiting
More China Medical University Hospital trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.